An Open-Label Extension Study to Evaluate the Safety and Efficacy of BG9924 When Given in Combination With Methotrexate to Subjects With Rheumatoid Arthritis Who Previously Participated in Study 104RA203.

Trial Profile

An Open-Label Extension Study to Evaluate the Safety and Efficacy of BG9924 When Given in Combination With Methotrexate to Subjects With Rheumatoid Arthritis Who Previously Participated in Study 104RA203.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 27 Jan 2016

At a glance

  • Drugs Baminercept (Primary) ; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors Biogen
  • Most Recent Events

    • 17 Jun 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
    • 16 Oct 2008 Actual patient number (72) added as reported by ClinicalTrials.gov.
    • 16 Oct 2008 Status changed from recruiting to discontinued as reportede by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top